Others argue the opposite, that consistent low-dose activation maintains the beneficial signaling
This approach is best suited to: Adults 4065 with longevity-focused health goals who are already engaged in foundational health optimisation (sleep, nutrition, resistance training, metabolic health) Individuals with confirmed age-related decline in GH/IGF-1, with symptoms including reduced lean mass, increased visceral fat, impaired recovery, or sleep-quality deterioration Patients with chronically elevated inflammatory markers without acute disease Adults with disrupted circadian rhythm or age-related sleep degradation (Epitalon specifically addresses this) Those who have optimised foundational lifestyle variables and want an additional, evidence-informed intervention layer It is not appropriate as a standalone intervention for adults who have not addressed metabolic health, sleep, or body composition fundamentals
Minet A, Manceau A, Valada-Mennuni A, BraultFavrou M, Churlaud C, Fort J, Nguyen TM, Spitz J, Bustamante P, LacoueLabarthe T (2020) Mercury in the tissues of five cephalopods species: first data on the nervous system
10.1016/j.brainresbull.2016.05.016 63
